Background: Attention has recently been focused on central nervous system n
europeptides as potential mediators of th symptom profile of obsessive-comp
ulsive disorder (OCD). Increased CSF levels of the anxiolytic neuropeptide
oxytocin have been reported in OCD. CSF levels of NPY, another anxiolytic n
europeptide, have not been studied.
Methods: We measured CSF oxytocin and NPY in 14 OCD patients and 26 healthy
normal volunteers.
Results: There were no significant differences between the OCD patients and
control subjects in CSF oxytocin or NPY levels. In both the OCD and contro
l groups, women had significantly higher CSF oxytocin levels than men.
Conclusions: These results do not support a prior finding of elevated CSF o
xytocin in OCD patients and do not provide any evidence for an abnormality
of NPY regulation in OCD. Biol Psychiatry 1999;45:931-933 (C) 1999 Society
of Biological Psychiatry.